Kalinox (Nitrous Oxide, Oxygen)

• Kalinox, a nitrous oxide/oxygen mixture, is used for analgesia and sedation in procedural settings.
• Procedural sedation: provides rapid onset sedation and pain relief during short medical procedures.
• Minor surgery: facilitates analgesia and patient comfort during minor operative interventions.
• Dental procedures: enables effective pain control and anxiety reduction during dental work.

• Nitrous oxide exerts its analgesic and sedative effects primarily through antagonism of NMDA receptors, which reduces excitatory neurotransmission, and by modulating endogenous opioid pathways, enhancing inhibitory signaling. The accompanying oxygen component maintains adequate tissue oxygenation during inhalation, supporting safe sedation and analgesia.

Kalinox may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Vomiting: occasional emesis during or after administration.
• Dizziness: transient light‑headedness.
• Headache: mild headache post‑procedure.
• Hypoxia: reduced oxygen saturation if not adequately supplemented.
• Euphoria: brief feeling of well‑being.

Serious or Rare Side Effects

• Respiratory depression: significant reduction in breathing effort.
• Loss of consciousness: unexpected deep sedation.
• Severe hypotension: marked drop in blood pressure.
• Allergic reaction: rash, itching, or anaphylaxis.
• Methemoglobinemia: rare blood disorder affecting oxygen transport.
• Cardiac arrhythmia: irregular heart rhythm.

When using Kalinox, clinicians should observe specific safety measures to minimize risk.

• Respiratory assessment: evaluate patient breathing function before and during use.
• Oxygen monitoring: continuously monitor SpO2 levels.
• COPD caution: use with heightened vigilance in chronic obstructive pulmonary disease.
• Anemia caution: avoid in patients with severe anemia.
• Pregnancy caution: safety in pregnancy is unknown; consider alternatives.
• Store at ambient temperature: keep cylinders upright, protect from heat and direct sunlight.

Kalinox can interact with other substances that affect the central nervous system or oxygen delivery.

Major Interactions (Avoid)

• Opioids: combined use may cause profound sedation and respiratory depression.
• Benzodiazepines: concurrent administration can enhance CNS depression.
• High‑flow oxygen therapy: may diminish nitrous oxide efficacy.

Moderate Interactions (Monitor Closely)

• Volatile anesthetics: may increase overall sedative effect.
• Alcohol: concurrent intake can potentiate dizziness and nausea.
• MAO inhibitors: may require closer monitoring of hemodynamic status.